In Vitro Activities of 2,4-Diaminoquinazoline and 2,4-Diaminopteridine Derivatives against Plasmodium falciparum

AUTOR(ES)

Ommeh, Sheila

FONTE

American Society for Microbiology

RESUMO

The activities of 28 6-substituted 2,4-diaminoquinazolines, 2,4-diamino-5,6,7,8-tetrahydroquinazolines, and 2,4-diaminopteridines against Plasmodium falciparum were tested. The 50% inhibitory concentrations (IC50s) of six compounds were <50 nM, and the most potent compound was 2,4-diamino-5-chloro-6-[N-(2,5-dimethoxybenzyl)amino]quinazoline (compound 1), with an IC50 of 9 nM. The activity of compound 1 was potentiated by the dihydropteroate synthase inhibitor dapsone, an indication that these compounds are inhibitors of dihydrofolate reductase. Further studies are warranted to assess the therapeutic potential of this combination in vivo.

Documentos Relacionados

• Activity of 2,4-Diaminoquinazoline Compounds against Candida species
• Antileishmanial activities of 2,4-diaminoquinazoline putative dihydrofolate reductase inhibitors.
• In vitro activities of furoquinoline and acridone alkaloids against Plasmodium falciparum.
• In Vitro Activities of Strychnos Alkaloids and Extracts against Plasmodium falciparum
• In Vitro Activities of Piperaquine and Other 4-Aminoquinolines against Clinical Isolates of Plasmodium falciparum in Cameroon